Beyond Ejection Fraction: Novel Clinical Approaches Towards Sudden Cardiac Death Risk Stratification in Patients with Dilated Cardiomyopathy.

Autor:	Pour-Ghaz I; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN, USA., Heckle M; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN, USA., Ifedili I; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN, USA., Kayali S; Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN, USA., Nance C; Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN, USA., Kabra R; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN, USA.; Methodist Le Bonheur Healthcare, Memphis, TN, USA., Jha SK; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN, USA.; Methodist Le Bonheur Healthcare, Memphis, TN, USA., Jefferies JL; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN, USA.; Methodist Le Bonheur Healthcare, Memphis, TN, USA., Levine YC; Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN, USA.; Methodist Le Bonheur Healthcare, Memphis, TN, USA.
Jazyk:	angličtina
Zdroj:	Current cardiology reviews [Curr Cardiol Rev] 2022; Vol. 18 (2), pp. e040821195265.
DOI:	10.2174/1573403X17666210804125939
Abstrakt:	Implantable Cardioverter-Defibrillator (ICD) therapy is indicated for patients at risk for sudden cardiac death due to ventricular tachyarrhythmia. The most commonly used risk stratification algorithms use Left Ventricular Ejection Fraction (LVEF) to determine which patients qualify for ICD therapy, even though LVEF is a better marker of total mortality than ventricular tachyarrhythmias mortality. This review evaluates imaging tools and novel biomarkers proposed for better risk stratifying arrhythmic substrate, thereby identifying optimal ICD therapy candidates. (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu